Specify a stock or a cryptocurrency in the search bar to get a summary
Acarix A/S
ACARIXAcarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden. Address: Regus MalmOe, Malmö, Sweden, 215 32
Analytics
WallStreet Target Price
5.43 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ACARIX
Dividend Analytics ACARIX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACARIX
Stock Valuation ACARIX
Financials ACARIX
Results | 2019 | Dynamics |